Also, if the pulmonary microenvironment in the animals treated with CPC in the model OVA-induced asthma has an anti-inflammatory state, then it is possible the production of pro-resolving molecules is enhanced because PCB does not affect the activity of lipoxygenase-5 (LOX), but CPC prevents the over-expression of COX2. The gene discussed is LOX; the disease is asthma.